Common Contracts
3 similar Placement Agency Agreement contracts by BiomX Inc., Lexicon Pharmaceuticals, Inc., Lilium N.V.
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • November 22nd, 2022 • Lilium N.V. • Aircraft • New York
BIOMX INC. PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 26th, 2021 • BiomX Inc. • Biological products, (no disgnostic substances) • New York
BiomX Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions of this Placement Agency Agreement (this “Agreement”) and the Purchase Agreement (as defined in Section 1(a) hereof), to sell to certain investors (each, an “Investor” and collectively, the “Investors”) an aggregate of 3,750,000 shares (the “Shares”) of the Company’s common stock, par value $0.0001 (the “Common Stock”), and warrants to purchase up to an aggregate of 2,812,501 shares of Common Stock (the “Warrants” and, together with the Shares, the “Securities”), in an offering under the Company’s registration statement on Form S-3 (Registration No. 333-251151). The Common Stock issuable pursuant to the terms of the Warrants are referred to herein as the “Warrant Shares”).
20,312,500 SHARES OF COMMON STOCK PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • December 11th, 2020 • Lexicon Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Lexicon Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions of this Placement Agency Agreement (the “Agreement”) and the Purchase Agreements (as defined in Section 1(a) hereof), to sell to certain investors (each, an “Investor” and collectively, the “Investors”) an aggregate of 20,312,500 shares (the “Shares”) of the Company’s common stock, par value $0.001 (the “Common Stock”), in an offering under the Company’s registration statement on Form S-3 (Registration No. 333-234568).
